Standout Papers
- Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1) (2019)
- Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression (2017)
- Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study (2019)
Immediate Impact
3 from Science/Nature 53 standout
Citing Papers
Long COVID science, research and policy
2024 Standout
Management of Depression in Adults
2024 Standout
Works of Ella Daly being referenced
Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study
2019 Standout
Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study
2015
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Ella Daly | 2316 | 736 | 1567 | 64 | 3.2k | |
| Dawn F. Ionescu | 1985 | 761 | 1552 | 52 | 3.0k | |
| Samuel T. Wilkinson | 2185 | 478 | 1144 | 85 | 3.1k | |
| Rosanne Lane | 1718 | 497 | 1152 | 41 | 3.0k | |
| Nancy Diazgranados | 2575 | 559 | 2198 | 77 | 4.3k | |
| Richard C. Shelton | 1451 | 541 | 1098 | 64 | 3.8k | |
| Cristina Cusin | 1454 | 575 | 1022 | 99 | 3.6k | |
| Mark J. Niciu | 2091 | 725 | 1857 | 64 | 4.1k | |
| Giacomo Salvadore | 1675 | 398 | 1584 | 51 | 3.3k | |
| Henrik Loft | 1752 | 1055 | 534 | 60 | 2.9k | |
| S. Danielle | 1438 | 815 | 1110 | 79 | 3.8k |
All Works
Login with ORCID to disown or claim papers
Loading papers...